Pharming Group N.V.
PHGUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $55 | $62 | $207 | $192 |
| Short-Term Investments | $113 | $152 | $0 | $0 |
| Receivables | $50 | $43 | $25 | $28 |
| Inventory | $56 | $57 | $42 | $27 |
| Other Curr. Assets | $5 | $4 | $3 | $3 |
| Total Curr. Assets | $278 | $316 | $278 | $249 |
| Property Plant & Equip (Net) | $24 | $33 | $39 | $33 |
| Goodwill | $0 | $0 | $0 | -$0 |
| Intangibles | $61 | $71 | $75 | $84 |
| Long-Term Investments | $4 | $10 | $10 | $10 |
| Tax Assets | $42 | $30 | $23 | $21 |
| Other NC Assets | -$10 | $2 | $1 | -$0 |
| Total NC Assets | $122 | $147 | $148 | $148 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $400 | $463 | $426 | $397 |
| Liabilities | – | – | – | – |
| Payables | $10 | $10 | $8 | $7 |
| Short-Term Debt | $7 | $5 | $5 | $4 |
| Tax Payable | $3 | $6 | $2 | $2 |
| Deferred Revenue | $0 | $0 | -$46 | -$35 |
| Other Curr. Liab. | $53 | $57 | $44 | $34 |
| Total Curr. Liab. | $74 | $78 | $60 | $47 |
| LT Debt | $105 | $166 | $159 | $157 |
| Deferred Rev, NC | $0 | $0 | -$6 | -$6 |
| Deferred Tax Liab, NC | $11 | $8 | $6 | $6 |
| Other NC Liab. | $0 | $0 | $2 | $0 |
| Total NC Liab. | $116 | $174 | $161 | $157 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $30 | $33 | $31 | $21 |
| Total Liabilities | $179 | $244 | $221 | $204 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $8 | $7 | $8 | $7 |
| Retained Earnings | -$275 | -$265 | -$256 | -$273 |
| AOCI | -$0 | -$2 | -$9 | $3 |
| Other Equity | $489 | $479 | $462 | $455 |
| Total Equity | $221 | $219 | $205 | $193 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $411 | $463 | $426 | $397 |
| Net Debt | $57 | $110 | -$43 | -$30 |